Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) updated its fourth quarter 2024 earnings guidance on Wednesday. The company provided EPS guidance of 0.100-0.140 for the period, compared to the consensus EPS estimate of 0.130. The company issued revenue guidance of $300.0 million-$310.0 million, compared to the consensus revenue estimate of $319.1 million. Cross Country Healthcare also updated its Q4 guidance to $0.10-$0.14 EPS.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on the stock. Barrington Research decreased their target price on shares of Cross Country Healthcare from $21.00 to $19.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Truist Financial lowered their price objective on Cross Country Healthcare from $17.00 to $15.00 and set a “hold” rating for the company in a research note on Monday, October 21st. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $18.75.
Check Out Our Latest Report on CCRN
Cross Country Healthcare Stock Performance
Cross Country Healthcare Company Profile
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Featured Stories
- Five stocks we like better than Cross Country Healthcare
- 3 Fintech Stocks With Good 2021 Prospects
- What a Trump Win Looks Like for the Market Now and Into 2025
- 3 Tickers Leading a Meme Stock Revival
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.